Technology has propelled advancements in the clinical trial landscape, with investigators utilising artificial intelligence (AI) and machine learning (ML) in…
Clinical Trials Arena spoke to Anthony T. Everhart, MD, FACP; Clinical Vice President at leading evidence generation company, Signant Health,…
From the Covid-19 pandemic to wars to natural disasters, the medical industry has faced a turbulent five years. In places…
Bristol Myers Squibb has presented three-year results from the POETYK PSO long-term extension trial (NCT04036435) of Sotyktu (deucravacitinib) for the…
UK private equity firm Permira has announced an agreement to purchase Ergomed for £703m ($888.1m). Ergomed specialises in clinical trial…
MapLight Therapeutics plans to start Phase II trials to evaluate the combination treatment of M1/M4 muscarinic receptor agonist (ML-007) and…
Cellectis has provided an update on three clinical trials AMELI-01, BALLI-01 and NATHALI-01 evaluating its three chimeric antigen receptor (CAR)…
Addex Therapeutics and Indivior have extended their research agreement for the drug discovery of novel oral gamma-aminobutyric acid subtype B…
In June 2023, a closure announcement from the National Cancer Research Institute (NCRI) shook the UK cancer community. The charity…
Aside from evaluating the safety and efficacy of a drug or device, clinical trials play other crucial roles. Lord O’Shaughnessy’s…
